These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12488288)

  • 1. The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.
    Miller KD; Sweeney CJ; Sledge GW
    Ann Oncol; 2003 Jan; 14(1):20-8. PubMed ID: 12488288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic therapy and p53.
    Hammond EM; Giaccia AJ
    Science; 2002 Jul; 297(5581):471; discussion 471. PubMed ID: 12142499
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenesis. A boost for tumor starvation.
    Marx J
    Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.
    Boehm T; Folkman J; Browder T; O'Reilly MS
    Nature; 1997 Nov; 390(6658):404-7. PubMed ID: 9389480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer research. Obstacle for promising cancer therapy.
    Marx J
    Science; 2002 Feb; 295(5559):1444. PubMed ID: 11859164
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to antiangiogenic therapies.
    Bartolotti M; Franceschi E; Poggi R; Tosoni A; Di Battista M; Brandes AA
    Future Oncol; 2014 Jun; 10(8):1417-25. PubMed ID: 25052752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy and p53.
    Browder T; Folkman J; Hahnfeldt P; Heymach J; Hlatky L; Kieran M; Rogers MS
    Science; 2002 Jul; 297(5581):471; discussion 471. PubMed ID: 12143876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
    Bout JC; Soncin F; Vandenbunder B
    Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiangiogenic tumour therapy: will it work?
    Augustin HG
    Trends Pharmacol Sci; 1998 Jun; 19(6):216-22. PubMed ID: 9666712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
    Yi M; Ruoslahti E
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):620-4. PubMed ID: 11209058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the orthotopic model to validate antivascular therapies for cancer.
    Loi M; Di Paolo D; Becherini P; Zorzoli A; Perri P; Carosio R; Cilli M; Ribatti D; Brignole C; Pagnan G; Ponzoni M; Pastorino F
    Int J Dev Biol; 2011; 55(4-5):547-55. PubMed ID: 21858775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behind the headlines of endostatin's ups and downs.
    Cohen J
    Science; 1999 Feb; 283(5406):1250-1. PubMed ID: 10084928
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
    Ellis LM
    J Clin Oncol; 2003 Dec; 21(23 Suppl):281s-283s. PubMed ID: 14645411
    [No Abstract]   [Full Text] [Related]  

  • 16. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiogenesis research. Cancer drugs found to work in new way.
    Barinaga M
    Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance associated with antiangiogenesis therapy.
    Eikesdal HP; Kalluri R
    Semin Cancer Biol; 2009 Oct; 19(5):310-7. PubMed ID: 19524042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.
    Yu MK; Lee DY; Kim YS; Park K; Park SA; Son DH; Lee GY; Nam JH; Kim SY; Kim IS; Park RW; Byun Y
    Pharm Res; 2007 Apr; 24(4):705-14. PubMed ID: 17318418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural compounds show antiangiogenic activity.
    Marwick C
    J Natl Cancer Inst; 2001 Nov; 93(22):1685. PubMed ID: 11717328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.